Table 2 Scoring of drugs with discrepant ratings (=ratings differed more than 1 score) or only one previous scoring
From: An anticholinergic burden score for German prescribers: score development
Drug | ATC-Code | Carnahan 2006 USA [20] | Ancelin 2006 France [21] | Rudolph 2008 USA [22] | Han 2008 USA [23] | Ehrt 2010 Norway modified [24] | Sittironnarit 2011 Australia [26] | Boustani 2012 USA [40] | Duran 2013 [18] |
|---|---|---|---|---|---|---|---|---|---|
No anticholinergic effects ACB score 0 | |||||||||
 Colchicine | M04 AC01 | 0 | 3 |  |  |  | 0 | 1 | discrepant |
Weak anticholinergic effects ACB score 1 | |||||||||
 Alprazolam | N05BA12 | 1 | 3 |  | 1 |  | 1 | 1 | discrepant |
 Asenapine | N05AH05 |  |  |  |  |  |  | 1 |  |
 Baclofen | M03BX01 | 0 |  | 2 | 2 |  |  |  | 1 or 2 |
 Cetirizine | R06AE07 | 0 |  | 2 | 2 |  | 2 | 1 | 1 or 2 |
 Clorazepate | N05BA05 | 1 | 3 |  |  |  |  | 1 | discrepant |
 Codeine | R05DA04 | 1 | 2 |  | 1 | 0 | 1 | 1 | 1 or 2 |
 Desloratadine | R06AX27 |  |  |  |  |  |  | 1 |  |
 Digoxin | C01AA05 | 1 | 3 |  |  | 1 | 1 | 1 | discrepant |
 Doxylamine | R06AA09 |  |  |  |  |  | 0 | 3 |  |
 Fexofenadine | R06AX26 | 0 |  |  | 2 |  | 2 | 0 | 1 or 2 |
 Fluphenazine | N05AB02 | 1 |  | 3 |  |  | 3 |  | 3 |
 Furosemide | C03CA01 | 1 | 3 |  |  | 1 | 0 | 1 | discrepant |
 Ipratropium inhalative | R03BB01 | 0 |  |  |  | 3 |  |  | 3 |
 Levocetirizine | R06AE09 |  |  |  |  |  |  | 1 |  |
 Loratadine | R06AX13 | 0 |  | 2 | 1 |  | 1 | 1 | 1 or 2 |
 Methocarbamol | M03BA03 |  |  | 1 | 1 |  |  | 3 | 1 or 2 |
 Metoclopramide | A03FA01 | 0 |  | 1 | 3 | 0 | 1 |  | discrepant |
 Paliperidone | N05AX13 |  |  |  |  |  |  | 1 |  |
 Perphenazine | N05AB03 | 1 |  | 3 | 2 | 0 |  | 3 | discrepant |
 Promethazine | R06AD02 | 3 |  | 3 |  |  | 0 | 3 | 3 |
 Pseudoephedrine | R01BA02 | 0 |  |  |  |  | 2 |  | 0 oder 1 |
 Tiotropium inhalative | R03BB04 |  |  |  |  |  | 0 |  |  |
Moderate anticholinergic effects ACB score 2 | |||||||||
 Carbamazepine | N03AF01 | 2 |  |  | 1 | 0 | 0 | 2 | 1 or 2 |
 Haloperidol | N05 AD01 | 0 |  | 1 |  | 0 | 2 | 1 | 1 or 2 |
 Maprotiline | N06AA21 |  | 3 |  |  |  |  |  | discrepant |
 Pethidine | N02AB02 | 2 |  |  |  | 0 |  | 2 | 1 or 2 |
 Olanzapine | N05AH03 | 1 |  | 2 | 1 | 2 |  | 3 | 1 or 2 |
 Opipramol | N06AA05 |  | 3 |  |  |  |  |  | discrepant |
 Paroxetine | N06AB05 | 1 |  | 1 | 2 | 2 | 2 | 3 | 1 or 2 |
 Quetiapine | N05AH04 | 0 |  | 1 | 2 | 1 |  | 3 | 1 or 2 |
Strong anticholinergic effects ACB score 3 | |||||||||
 Fesoterodine | G04BD11 |  |  |  |  |  |  | 3 |  |
 Propiverine | G04BD06 |  |  |  |  |  |  | 3 |  |
 Solifenacin | G04BD08 |  |  |  |  |  | 0 | 3 |  |
 Trospium | G04BD09 |  |  |  |  |  |  | 3 |  |